In Utero Hematopoietic Cell Transplantation for the Treatment of Congenital Anomalies

Clinics in Perinatology

Volumn 39, Issue 2, 2012, Pages 301-310

  Nijagal, Amar ^a   Flake, Alan W ^b   MacKenzie, Tippi C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chimerism; Engraftment; Hematopoietic stem cells; In utero transplantation; Maternal immune response; Stem cell transplantation

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONGENITAL MALFORMATION; FETUS SURGERY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGICAL TOLERANCE; IN UTERO STEM CELL TRANSPLANTATION; LEUKOCYTE ADHESION DEFICIENCY; NONHUMAN; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PATIENT SAFETY; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SICKLE CELL ANEMIA; THALASSEMIA; THERAPY EFFECT;

ANIMALS; CHIMERISM; DISEASE MODELS, ANIMAL; FETUS; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE TOLERANCE; MICE;

EID: 84862151147     PISSN: 00955108     EISSN: 15579840     Source Type: Journal    
DOI: 10.1016/j.clp.2012.04.004     Document Type: Review

References (72)

1. Harrison M.R., Golbus M.S., Filly R.A., et al. Fetal surgery for congenital hydronephrosis. N Engl J Med 1982, 306(10):591-593.
2. Sydorak R.M., Nijagal A., Albanese C.T. Endoscopic techniques in fetal surgery. Yonsei Med J 2001, 42(6):695-710.
3. Johnson F.L., Look A.T., Gockerman J., et al. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med 1984, 311(12):780-783.
4. Kamani N., August C.S., Douglas S.D., et al. Bone marrow transplantation in chronic granulomatous disease. J Pediatr 1984, 105(1):42-46.
5. Lucarelli G., Galimberti M., Polchi P., et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990, 322(7):417-421.
6. Parkman R. The application of bone marrow transplantation to the treatment of genetic diseases. Science 1986, 232(4756):1373-1378.
7. Santore M.T., Roybal J.L., Flake A.W. Prenatal stem cell transplantation and gene therapy. Clin Perinatol 2009, 36(2):451-471. xi.
8. Elder M., Golbus M.S., Cowan M.J. Ontogeny of T- and B-cell immunity. Fetal tissue transplants in medicine 1992, 97-128. University Press, Cambridge (UK). R.G. Edwards (Ed.).
9. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86(6):897-906.
10. Palmer E. Negative selection-clearing out the bad apples from the T-cell repertoire. Nat Rev Immunol 2003, 3(5):383-391.
11. Ashizuka S., Peranteau W.H., Hayashi S., et al. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol 2006, 34(3):359-368.
12. Hayashi S., Peranteau W.H., Shaaban A.F., et al. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 2002, 100(3):804-812.
13. Peranteau W.H., Hayashi S., Hsieh M., et al. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood 2002, 100(6):2225-2234.
14. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945, 102(2651):400-401.
15. Thomsen M., Hansen H.E., Dickmeiss E. MLC and CML studies in the family of a pair of HLA haploidentical chimeric twins. Scand J Immunol 1977, 6(5):523-528.
16. Picus J., Aldrich W.R., Letvin N.L. A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system. Transplantation 1985, 39(3):297-303.
17. Picus J., Holley K., Aldrich W.R., et al. A naturally occurring bone marrow-chimeric primate. II. Environment dictates restriction on cytolytic T lymphocyte-target cell interactions. J Exp Med 1985, 162(6):2035-2052.
18. Mold J.E., Michaelsson J., Burt T.D., et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008, 322(5907):1562-1565.
19. Suskind D.L., Rosenthal P., Heyman M.B., et al. Maternal microchimerism in the livers of patients with biliary atresia. BMC Gastroenterol 2004, 4:14.
20. Nijagal A., Fleck S., Hills N.K., et al. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant 2012, 12(2):409-419.
21. Burlingham W.J., Grailer A.P., Heisey D.M., et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998, 339(23):1657-1664.
22. van Rood J.J., Loberiza F.R., Zhang M.J., et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002, 99(5):1572-1577.
23. Hayashi S., Abdulmalik O., Peranteau W.H., et al. Mixed chimerism following in utero hematopoietic stem cell transplantation in murine models of hemoglobinopathy. Exp Hematol 2003, 31(2):176-184.
24. Peranteau W.H., Heaton T.E., Gu Y.C., et al. Haploidentical in utero hematopoietic cell transplantation improves phenotype and can induce tolerance for postnatal same-donor transplants in the canine leukocyte adhesion deficiency model. Biol Blood Marrow Transplant 2009, 15(3):293-305.
25. Billingham R.E., Brent L., Medawar P.B. Actively acquired tolerance of foreign cells. Nature 1953, 172(4379):603-606.
26. Blazar B.R., Taylor P.A., Vallera D.A. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood 1995, 86(11):4353-4366.
27. Blazar B.R., Taylor P.A., Vallera D.A. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood 1995, 85(3):833-841.
28. Fleischman R.A., Mintz B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta. Proc Natl Acad Sci U S A 1979, 76(11):5736-5740.
29. Fleischman R.A., Mintz B. Development of adult bone marrow stem cells in H-2-compatible and -incompatible mouse fetuses. J Exp Med 1984, 159(3):731-745.
30. Peranteau W.H., Endo M., Adibe O.O., et al. Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood 2007, 109(3):1331-1333.
31. Merianos D.J., Tiblad E., Santore M.T., et al. Maternal alloantibodies induce a postnatal immune response that limits engraftment following in utero hematopoietic cell transplantation in mice. J Clin Invest 2009, 119(9):2590-2600.
32. Nijagal A., Wegorzewska M., Jarvis E., et al. Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice. J Clin Invest 2011, 121(2):582-592.
33. Kim H.B., Shaaban A.F., Milner R., et al. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surg 1999, 34(5):726-729. [discussion: 9-30].
34. Hayashi S., Hsieh M., Peranteau W.H., et al. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes. Exp Hematol 2004, 32(3):290-299.
35. Durkin E.T., Jones K.A., Rajesh D., et al. Early chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras. Blood 2008, 112(13):5245-5253.
36. Flake A.W., Harrison M.R., Adzick N.S., et al. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986, 233(4765):776-778.
37. Almeida-Porada G., Porada C., Gupta N., et al. The human-sheep chimeras as a model for human stem cell mobilization and evaluation of hematopoietic grafts' potential. Exp Hematol 2007, 35(10):1594-1600.
38. Zanjani E.D., Flake A.W., Rice H., et al. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 1994, 93(3):1051-1055.
39. Zanjani E.D., Pallavicini M.G., Ascensao J.L., et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992, 89(4):1178-1188.
40. Narayan A.D., Chase J.L., Lewis R.L., et al. Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients. Blood 2006, 107(5):2180-2183.
41. Liechty K.W., MacKenzie T.C., Shaaban A.F., et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000, 6(11):1282-1286.
42. Omori F., Lutzko C., Abrams-Ogg A., et al. Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses. Exp Hematol 1999, 27(2):242-249.
43. Lee P.W., Cina R.A., Randolph M.A., et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in swine. Transplantation 2005, 79(9):1084-1090.
44. Shields L.E., Gaur L.K., Gough M., et al. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 2003, 21(3):304-314.
45. Tarantal A.F., Goldstein O., Barley F., et al. Transplantation of human peripheral blood stem cells into fetal rhesus monkeys (Macaca mulatta). Transplantation 2000, 69(9):1818-1823.
46. Asano T., Ageyama N., Takeuchi K., et al. Engraftment and tumor formation after allogeneic in utero transplantation of primate embryonic stem cells. Transplantation 2003, 76(7):1061-1067.
47. Flake A.W., Zanjani E.D. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 1999, 94(7):2179-2191.
48. Touraine J.L., Raudrant D., Royo C., et al. In-utero transplantation of stem cells in bare lymphocyte syndrome. Lancet 1989, 1(8651):1382.
49. Flake A.W., Roncarolo M.G., Puck J.M., et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996, 335(24):1806-1810.
50. Wengler G.S., Lanfranchi A., Frusca T., et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996, 348(9040):1484-1487.
51. Touraine J.L., Raudrant D., Laplace S. Transplantation of hemopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally. Transplant Proc 1997, 29(1-2):712-713.
52. Gil J., Porta F., Bartolome J., et al. Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells. Transplant Proc 1999, 31(6):2581.
53. Pirovano S., Notarangelo L.D., Malacarne F., et al. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output. Haematologica 2004, 89(4):450-461.
54. Mintz B., Anthony K., Litwin S. Monoclonal derivation of mouse myeloid and lymphoid lineages from totipotent hematopoietic stem cells experimentally engrafted in fetal hosts. Proc Natl Acad Sci U S A 1984, 81(24):7835-7839.
55. Stewart F.M., Zhong S., Wuu J., et al. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood 1998, 91(10):3681-3687.
56. Peranteau W.H., Endo M., Adibe O.O., et al. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 2006, 108(13):4268-4274.
57. Lindton B., Tolfvenstam T., Norbeck O., et al. Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro. Fetal Diagn Ther 2001, 16(1):26-31.
58. Czechowicz A., Kraft D., Weissman I.L., et al. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 2007, 318(5854):1296-1299.
59. Flake A.W., Zanjani E.D. Cellular therapy. Obstet Gynecol Clin North Am 1997, 24(1):159-177.
60. Shaaban A.F., Kim H.B., Milner R., et al. A kinetic model for the homing and migration of prenatally transplanted marrow. Blood 1999, 94(9):3251-3257.
61. Taylor P.A., McElmurry R.T., Lees C.J., et al. Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients. Blood 2002, 99(5):1870-1872.
62. Golombeck K., Ball R.H., Lee H., et al. Maternal morbidity after maternal-fetal surgery. Am J Obstet Gynecol 2006, 194(3):834-839.
63. Mackenzie T.C., Shaaban A.F., Radu A., et al. Engraftment of bone marrow and fetal liver cells after in utero transplantation in MDX mice. J Pediatr Surg 2002, 37(7):1058-1064.
64. Sabatino D.E., Mackenzie T.C., Peranteau W., et al. Persistent expression of hF.IX After tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol Ther 2007, 15(9):1677-1685.
65. Ye L., Chang J.C., Lin C., et al. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A 2009, 106(24):9826-9830.
66. Howson-Jan K., Matloub Y.H., Vallera D.A., et al. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation 1993, 56(3):709-716.
67. Frattini A., Blair H.C., Sacco M.G., et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci U S A 2005, 102(41):14629-14634.
68. Tondelli B., Blair H.C., Guerrini M., et al. Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc/oc mouse. Am J Pathol 2009, 174(3):727-735.
69. Panaroni C., Gioia R., Lupi A., et al. In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009, 114(2):459-468.
70. Archer D.R., Turner C.W., Yeager A.M., et al. Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 1997, 90(8):3222-3229.
71. Liuba K., Pronk C.J., Stott S.R., et al. Polyclonal T-cell reconstitution of X-SCID recipients after in utero transplantation of lymphoid-primed multipotent progenitors. Blood 2009, 113(19):4790-4798.
72. Waldschmidt T.J., Panoskaltsis-Mortari A., McElmurry R.T., et al. Abnormal T cell-dependent B-cell responses in SCID mice receiving allogeneic bone marrow in utero. Severe combined immune deficiency. Blood 2002, 100(13):4557-4564.